The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol’s native token.
You might also be interested in reading Snowflake in spotlight as TD Cowen sees ‘constructive’ partner checks ahead of Q4 results.